Achieving Remission as a Routine Goal of Pharmacotherapy in Attention-Deficit Hyperactivity Disorder

Author： Ramos-Quiroga J. Antoni   Casas Miguel  

Publisher： Adis International

ISSN： 1172-7047

Source： CNS Drugs, Vol.25, Iss.1, 2011-01, pp. : 17-36

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacotherapy of Attention-Deficit Hyperactivity Disorder in Adolescents

By Childress Ann C.  

Drugs, Vol. 72, Iss. 3, 2012-02 ,pp. : 309-325

Adis International

Access to resources Recommend Favorite

Attention-Deficit Hyperactivity Disorder: Recent Advances in Paediatric Pharmacotherapy

By May Diane E.   Kratochvil Christopher J.  

Drugs, Vol. 70, Iss. 1, 2010-01 ,pp. : 15-40

Adis International

Access to resources Recommend Favorite

Pharmacotherapy of Attention-Deficit, Hyperactivity, and Impulsiveness in Autism Spectrum Disorder

By  

Child and Adolescent Psychopharmacology News, Vol. 21, Iss. 3, 2016-06 ,pp. : 10-13

Guilford Publications Inc

Access to resources Recommend Favorite

Pharmacotherapy of Attention Deficit Hyperactivity Disorder in Adults

By Wilens T.E.   Biederman J.   Spencer T.J.  

CNS Drugs, Vol. 9, Iss. 5, 1998-05 ,pp. : 347-356

Adis International

Access to resources Recommend Favorite

Pharmacotherapy for Parents with Attention-Deficit Hyperactivity Disorder (ADHD): Impact on Maternal ADHD and Parenting

By Chronis-Tuscano Andrea  

CNS Drugs, Vol. 26, Iss. 9, 2012-09 ,pp. : 725-732

Adis International

Access to resources Recommend Favorite